Tom Cavanaugh
Equibles does not estimate personal net worth.
Get an email with a short summary when Johnson & Johnson publishes a filing, an earnings call transcript or a press release.
Get JNJ alertsAbout Tom Cavanaugh
Johnson & Johnson reported in an 8-K filed August 4, 2026 that Tom Cavanaugh was appointed Executive Vice President, Worldwide Chairman, Innovative Medicine, effective September 1, 2026. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Daniel Pinto (Board Member) and 7 others.
“Jennifer will be succeeded by Tom Cavanaugh who currently serves as Company Group Chairman, North America, Innovative Medicine.”
Affiliation history
-
Johnson & Johnson (JNJ)
SEC 8-K
Current2026-09-01–present
Company network
Leadership on record at Johnson & Johnson
- J. Wolk CFO
- D. E. Pinto Board Member
- Daniel Pinto Board Member
- Darius Adamczyk Board Member
- Dr. Nadja West Board Member
- E. A. Woods Board Member
- Eugene A. Woods Board Member
- H. Joly Board Member
- J. A. Doudna Board Member
- J. Duato Board Member